SCHEMBL9993662

SCHEMBL9993662

CC(C)(O)CCCCCC1C=CC(=O)O1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PDCD4 Q53EL6 2/20 0.31
▸ ELANE P08246 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9992232 0.94 ELANE (0.32) ELANE
SCHEMBL9992410 0.87 CES2 (0.32) PDCD4
SCHEMBL17866952 0.84 PDCD4 (0.33) PDCD4
SCHEMBL9995108 0.80 PDCD4 (0.30) PDCD4
SCHEMBL1895638 0.78 PDCD4 (0.43) PDCD4
SCHEMBL8985124 0.78 PDCD4 (0.43) PDCD4
SCHEMBL12673923 0.78 PDCD4 (0.43) PDCD4
SCHEMBL31264316 0.78 NLRP3 (0.34) PDCD4
SCHEMBL31264317 0.78 NLRP3 (0.34) PDCD4
SCHEMBL9993971 0.78 XPO1 (0.33) PDCD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11421223-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. (US) 2022-08-23 — — US disclosed
US-20190309289-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. 2019-10-10 — — US disclosed
US-10370654-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. (US) 2019-08-06 — — US disclosed
US-20180320170-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. 2018-11-08 — — US disclosed
US-9944925-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. 2018-04-17 — — US disclosed
US-20160186168-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. 2016-06-30 — — US disclosed
US-8177896-B2 Antifouling furan-2-one derivatives THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2012-05-15 — — US disclosed
US-8177896-B2 Antifouling furan-2-one derivatives THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2012-05-15 — — US disclosed
US-20110185944-A1 ANTIFOULING FURAN-2-ONE DERIVATIVES THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2011-08-04 — — US disclosed
US-20110185944-A1 ANTIFOULING FURAN-2-ONE DERIVATIVES THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2011-08-04 — — US disclosed
WO-2010009632-A1 ANTIFOULING FURAN-2-ONE DERIVATIVES THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2010-01-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110185944-A1 ANTIFOULING FURAN-2-ONE DERIVATIVES FSCN1, PFAS, PFN1 PDCD4 3370/4885ELANE 2537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback